/People

Sharon Tan

Investor

Executive in Residence at Iaso Ventures

Boston, Massachusetts, United States

Find your path to Sharon

429 people in our graph can introduce you to Sharon.

Sign up to see every warm intro you have to Sharon

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Sharon. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Executive in Residence with over 20 years in clinical and preclinical development and pipeline strategy, focused on rare diseases and gene therapy. Held program leadership roles at Garuda Therapeutics, enGene, Ultragenyx and Sanofi Genzyme, including leading the FDA-approved Xenpozyme program.

Experience

  1. Tangram Development Solutions, LLCBiotech consultantcurrent2023 — presentBoston MA
  2. NLS Pharmaceutics AGHead of Program Management and Strategycurrent2023 — present
  3. Garuda TherapeuticsVice President Program Management2022 — 2023Cambridge, Massachusetts, United States
  4. enGeneVP & Head of Program Management (& Leadership)2019 — 2022
  5. Ultragenyx Gene TherapyExecutive Director, Program Team Lead2018 — 2019Cambridge, Massachusetts
  6. EnzyvantExecutive Director, Program Management2017 — 2018Cambridge MA
  7. Genzyme, a sanofi companyDirector / Sr. Director, Global Project Head2014 — 2017
  8. Genzyme, a sanofi companySr. Manager & Associate Director, Program Management2010 — 2014
  9. Boston Scientific CorporationR&D Program Manager2006 — 2010
  10. Boston Scientific CorporationSr. Scientist2001 — 2006
  11. Cardinal HealthPrincipal Engineer1997 — 2001
  12. Allegiance Healthcare/Cardinal HealthPrincipal R&D engineer1996 — 2001
  13. Baxter HealthcareChemist1995 — 1996

Skills & more

PMP10Medical Devices31Design Control15Biotechnology36Product Development38Commercialization18Drug Development1

From Sharon's professional profile.

Colleagues at Iaso Ventures

Frequently asked questions

Who is Sharon Tan?
Executive in Residence with over 20 years in clinical and preclinical development and pipeline strategy, focused on rare diseases and gene therapy. Held program leadership roles at Garuda Therapeutics, enGene, Ultragenyx and Sanofi Genzyme, including leading the FDA-approved Xenpozyme program.
Where does Sharon Tan work?
Sharon Tan is Executive in Residence at Iaso Ventures.
Where did Sharon Tan go to school?
Sharon Tan studied at D'Amore-McKim School of Business at Northeastern University (MBA); Simon Fraser University (BSc, Biochemistry); PMI (PMP certified).

Same school

Shared employers